Abstract
The therapeutic efficacy of Viferon (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol as a reference drug in the treatment of patients with influenza. Viferon and Arbidol lowered the signs of the fever, intoxication, catarrh and the disease as the whole.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Antiviral Agents / adverse effects
-
Antiviral Agents / therapeutic use*
-
Double-Blind Method
-
Female
-
Humans
-
Indoles / adverse effects
-
Indoles / therapeutic use*
-
Influenza, Human / drug therapy*
-
Interferon alpha-2
-
Interferon-alpha / adverse effects
-
Interferon-alpha / therapeutic use*
-
Male
-
Middle Aged
-
Recombinant Proteins
-
Suppositories
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Indoles
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Suppositories
-
umifenovir